Zydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US Ruchika Sharma18 Feb 2025 11:30 AM ISTAhmedabad: Zydus Lifesciences Ltd., a global healthcare company has announced that its wholly owned subsidiary, Zydus Lifesciences Global...
Low-dose-rate brachytherapy improves recurrence-free survival for recurrent prostate cancer: Study Jacinthlyn Sylvia16 Feb 2025 8:15 PM ISTA new study published in the British Journal of Urology International found that salvage low-dose-rate brachytherapy (LDR-BT) provides a higher...
Study shows urine test for prostate cancer could be used at home Dr. Kamal Kant Kohli5 Feb 2025 9:45 PM ISTResearchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate....
Urine-based test detects aggressive prostate cancer: Study Dr. Kamal Kant Kohli31 Jan 2025 8:30 PM ISTTraditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of...
Medical Bulletin 31/ January/ 2025 Dr. Bhumika Maikhuri31 Jan 2025 3:00 PM ISTHere are the top medical news for the day:Can Moderate Intensity Exercise Control Appetite?A recent study involving researchers at Murdoch...
Study Reveals Urine-Based Test Detects Aggressive Prostate Cancer Dr. Bhumika Maikhuri31 Jan 2025 8:45 AM ISTIn a new study, researchers have clinically validated a previously developed urine test, which can potentially bypass the invasive procedures done to...
Rare case of Prostate Cancer presenting as Oral Swelling: A Report Medha Baranwal10 Jan 2025 6:00 AM ISTAustralia: A rare and alarming case of prostate cancer presenting as an oral swelling emphasizes the importance of vigilance in dental practice,...
Medical Bulletin 08/ January/ 2025 Dr. Bhumika Maikhuri8 Jan 2025 3:00 PM ISTHere are the top medical news for the day:Advanced Imaging Reveals Undetected Metastases in High-Risk Prostate Cancer Patients: Study FindsA new study...
Bayer partner seeks approval for Darolutamide plus androgen deprivation therapy for metastatic hormone sensitive prostate cancer Ruchika Sharma8 Jan 2025 12:30 PM ISTOrion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National Medical Products...
Advanced Imaging Reveals Undetected Metastases in High-Risk Prostate Cancer Patients: Study Finds Dr. Bhumika Maikhuri8 Jan 2025 8:00 AM ISTA new study published in JAMA Network Open found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by...
Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases: JAMA Dr. Kamal Kant Kohli6 Jan 2025 9:15 PM ISTA new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic...
Stereotactic body radiotherapy Noninferior to Conventional Radiotherapy for Low-to-Intermediate Risk Prostate Cancer: Study Dr Riya Dave3 Jan 2025 9:45 PM ISTResearchers have found that stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately hypofractionated radiotherapy for...
